Literature DB >> 8313259

Reflections on a month in the life of the Ontario Drug Benefit Plan.

W McIsaac, C D Naylor, G M Anderson, B J O'Brien.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8313259      PMCID： PMC1486283     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  23 in total

1.  The publication of sponsored symposiums in medical journals.

Authors:  L A Bero; A Galbraith; D Rennie
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

2.  Health policy on blood cholesterol. Time to change directions.

Authors:  S B Hulley; J M Walsh; T B Newman
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

3.  The Nelson general practice prescribing project. Part I: A pilot audit of the regional prescribing profile.

Authors:  R I Ferguson; T J Maling
Journal:  N Z Med J       Date:  1990-11-28

4.  Pharmaceutical advertisements in leading medical journals: experts' assessments.

Authors:  M S Wilkes; B H Doblin; M F Shapiro
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

5.  A congressional perspective on inappropriate drug therapy and drug utilization review.

Authors:  D G Schulke
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

6.  Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.

Authors:  G M Anderson; K J Kerluke; I R Pulcins; C Hertzman; M L Barer
Journal:  Inquiry       Date:  1993       Impact factor: 1.730

7.  Characteristics of pharmaceutical opinions written in a Quebec community pharmacy.

Authors:  J Dumas; J Matte
Journal:  Ann Pharmacother       Date:  1992-06       Impact factor: 3.154

8.  A population-wide profile of prescription drug use in Saskatchewan, 1989.

Authors:  K Quinn; M J Baker; B Evans
Journal:  CMAJ       Date:  1992-06-15       Impact factor: 8.262

9.  Lowering cholesterol: effects on trauma death, cancer death and total mortality.

Authors:  S MacMahon
Journal:  Aust N Z J Med       Date:  1992-10

10.  Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

Authors:  C D Naylor; E Chen; B Strauss
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391
View more
  9 in total

1.  Practitioners and health policy. Case of the Ontario Drug Benefit Plan.

Authors:  S E Shortt
Journal:  Can Fam Physician       Date:  1995-12       Impact factor: 3.275

2.  Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.

Authors:  S Mahood; C Zagozeski; T Bradel; K Lawrence
Journal:  Can Fam Physician       Date:  1997-11       Impact factor: 3.275

Review 3.  Formulary management of drugs for cancer-associated hypercalcaemia.

Authors:  S J Gallacher
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

4.  Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.

Authors:  R F Tasch; R Goeree; C J Henke; B J O'Brien
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

5.  Variability in prescription drug utilization: issues for research.

Authors:  A H Anis; S G Carruthers; A O Carter; J Kierulf
Journal:  CMAJ       Date:  1996-03-01       Impact factor: 8.262

Review 6.  The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.

Authors:  A M Holbrook; R Crowther; A Lotter; C Cheng; D King
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262

7.  The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives.

Authors:  Sibyl Anthierens; Hilde Habraken; Mirko Petrovic; Thierry Christiaens
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

8.  Access to medicines: relations with the institutionalization of pharmaceutical services.

Authors:  Rafael Damasceno de Barros; Ediná Alves Costa; Djanilson Barbosa Dos Santos; Gisélia Santana Souza; Juliana Álvares; Augusto Afonso Guerra; Francisco de Assis Acurcio; Ione Aquemi Guibu; Karen Sarmento Costa; Margô Gomes de Oliveira Karnikowski; Orlando Mario Soeiro; Silvana Nair Leite
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

9.  Regional drug information center disseminates educational materials related to the COVID-19 pandemic.

Authors:  Jaqueline Rocha Borges Dos Santos
Journal:  Explor Res Clin Soc Pharm       Date:  2021-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.